Paylocity chairman Beauchamp sells 15,000 shares

The reported sales were conducted under an approved Rule 10b5-1 plan adopted August 19, 2025, and amended May 15, 2026.

Rhea-AI Filing Summary

Paylocity Holding Corp (PCTY) Executive Chairman Steven R. Beauchamp reported direct sales of 15,000 common shares on October 15, 2026, in five tranches: 600 at a weighted-average $161.38, 600 at $162.84, 1,400 at $164.27, 5,600 at $165.22, and 6,800 at $165.96 per share. The sales were under an approved Rule 10b5-1 plan adopted August 19, 2025, and amended May 15, 2026.

Separate indirect holding entries dated October 15, 2026 list 235,000 shares by IRIE Family Trust, 220,000 by SRB 2025 GRAT, 15,800 by IRIE Foundation, and 194,926 by Gotham Triple Advantage Strategy LP.

Insider Trade Summary 10b5-1

Net Seller: 15,000 shares

Net Sell 9 txns

Insider Beauchamp Steven R

Role Executive Chairman

Sold 15,000 shs ($2.48M)

Type	Security	Shares	Price	Value
Sale	Common Stock, par value $0.001 F1, F2	600	$161.38	$97K
Sale	Common Stock, par value $0.001 F1, F3	600	$162.84	$98K
Sale	Common Stock, par value $0.001 F1, F4	1,400	$164.27	$230K
Sale	Common Stock, par value $0.001 F1, F5	5,600	$165.22	$925K
Sale	Common Stock, par value $0.001 F1, F6	6,800	$165.96	$1.13M
holding	Common Stock, par value $0.001	--	--	--
holding	Common Stock, par value $0.001	--	--	--
holding	Common Stock, par value $0.001	--	--	--
holding	Common Stock, par value $0.001	--	--	--

Holdings After Transaction: Common Stock, par value $0.001 — 1,243,389 shares (Direct); Common Stock, par value $0.001 — 235,000 shares (Indirect, by IRIE Family Trust); Common Stock, par value $0.001 — 220,000 shares (Indirect, by SRB 2025 GRAT); Common Stock, par value $0.001 — 15,800 shares (Indirect, by IRIE Foundation); Common Stock, par value $0.001 — 194,926 shares (Indirect, by Gotham Triple Advantage Strategy LP)

Footnotes (6)

1. F1. The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 19, 2025 and amended on May 15, 2026.
2. F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.99 to $161.76, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2, 3, 4, 5 and 6 of this Form 4.
3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.45 to $163.31, inclusive.
4. F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.63 to $164.62, inclusive.
5. F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.65 to $165.64, inclusive.
6. F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.68 to $166.37, inclusive.

Key Figures

Shares sold: 15,000 shares Weighted-average sale: 600 shares at $161.38 per share Weighted-average sale: 600 shares at $162.84 per share +4 more

7 metrics

Shares sold 15,000 shares October 15, 2026

Weighted-average sale 600 shares at $161.38 per share October 15, 2026; reported price range $160.99 to $161.76 per share, inclusive

Weighted-average sale 600 shares at $162.84 per share October 15, 2026; reported price range $162.45 to $163.31 per share, inclusive

Weighted-average sale 1,400 shares at $164.27 per share October 15, 2026; reported price range $163.63 to $164.62 per share, inclusive

Weighted-average sale 5,600 shares at $165.22 per share October 15, 2026; reported price range $164.65 to $165.64 per share, inclusive

Weighted-average sale 6,800 shares at $165.96 per share October 15, 2026; reported price range $165.68 to $166.37 per share, inclusive

Indirect share holdings IRIE Family Trust: 235,000 shares; SRB 2025 GRAT: 220,000 shares; IRIE Foundation: 15,800 shares; Gotham Triple Advantage Strategy LP: 194,926 shares Holding entries dated October 15, 2026

Key Terms

10b5-1 Plan, weighted average price, par value

3 terms

10b5-1 Plan regulatory

"under an approved 10b5-1 Plan"

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

weighted average price financial

"price reported in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

par value financial

"Common Stock, par value $0.001"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PCTY shares did Steven R. Beauchamp sell, and at what prices?

Steven R. Beauchamp sold 15,000 shares on October 15, 2026, across five tranches: 600 at a weighted-average $161.38, 600 at $162.84, 1,400 at $164.27, 5,600 at $165.22, and 6,800 at $165.96 per share. The sales were under an approved Rule 10b5-1 plan adopted August 19, 2025, and amended May 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/16/2026 - 04:18 PM EDT Accepted by SEC EDGAR 10/16/2026 - 04:17 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beauchamp Steven R

(Last) (First) (Middle)

C/O 1400 AMERICAN LANE

(Street)

SCHAUMBURG ILLINOIS 60173

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Paylocity Holding Corp [ PCTY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.001	10/15/2026		S		600(1)	D	$161.38(2)	1,257,789	D
Common Stock, par value $0.001	10/15/2026		S		600(1)	D	$162.84(3)	1,257,189	D
Common Stock, par value $0.001	10/15/2026		S		1,400(1)	D	$164.27(4)	1,255,789	D
Common Stock, par value $0.001	10/15/2026		S		5,600(1)	D	$165.22(5)	1,250,189	D
Common Stock, par value $0.001	10/15/2026		S		6,800(1)	D	$165.96(6)	1,243,389	D
Common Stock, par value $0.001								235,000	I	by IRIE Family Trust
Common Stock, par value $0.001								220,000	I	by SRB 2025 GRAT
Common Stock, par value $0.001								15,800	I	by IRIE Foundation
Common Stock, par value $0.001								194,926	I	by Gotham Triple Advantage Strategy LP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 19, 2025 and amended on May 15, 2026.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.99 to $161.76, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2, 3, 4, 5 and 6 of this Form 4.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.45 to $163.31, inclusive.

4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.63 to $164.62, inclusive.

5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.65 to $165.64, inclusive.

6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.68 to $166.37, inclusive.

Remarks:

	/s/ Kris Kang, attorney-in-fact to Steven R. Beauchamp	10/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)